(Q40352195)
Statements
Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation (English)
Luigi D Notarangelo
Imelda C Hanson
Thomas A Fleisher
Troy R Torgerson
Lisa R Forbes
Louis-Marie Charbonnier
Fayhan Alroqi
Ashley Plant
Qi Qiao
Hao Wu
Clement Ma
Sergio D Rosenzweig